Wang S - Search Results

1

Oral topotecan: Bioavailability, pharmacokinetics and impact of ABCG2 genotyping in Chinese patients with advanced cancers.

Li N, Song Y, Du P, Shen Y, Yang J, Gui L, Wang S, Wang J, Sun Y, Han X, Shi Y. Li N, et al. Among authors: wang j, wang s. Biomed Pharmacother. 2013 Oct;67(8):801-6. doi: 10.1016/j.biopha.2013.08.002. Epub 2013 Sep 12. Biomed Pharmacother. 2013. PMID: 24074809 Clinical Trial.

2

[Detection of epidermal growth factor receptor gene mutations in advanced non-small cell lung cancer].

Wang S, Han XH, Li JL, Hu XS, Wang XY, Gui L, Zhao LD, Sun Y, Shi YK. Wang S, et al. Among authors: wang xy. Zhonghua Bing Li Xue Za Zhi. 2012 Aug;41(8):530-3. doi: 10.3760/cma.j.issn.0529-5807.2012.08.005. Zhonghua Bing Li Xue Za Zhi. 2012. PMID: 23157744 Chinese.

3

Direct sequencing is a reliable assay with good clinical applicability for KRAS mutation testing in colorectal cancer.

Wang J, Yang H, Shen Y, Wang S, Lin D, Ma L, Han X, Shi Y. Wang J, et al. Among authors: wang s. Cancer Biomark. 2013;13(2):89-97. doi: 10.3233/CBM-130334. Cancer Biomark. 2013. PMID: 23838137

4

Effectors of epidermal growth factor receptor pathway: the genetic profiling ofKRAS, BRAF, PIK3CA, NRAS mutations in colorectal cancer characteristics and personalized medicine.

Shen Y, Wang J, Han X, Yang H, Wang S, Lin D, Shi Y. Shen Y, et al. Among authors: wang j, wang s. PLoS One. 2013 Dec 10;8(12):e81628. doi: 10.1371/journal.pone.0081628. eCollection 2013. PLoS One. 2013. PMID: 24339949 Free PMC article.

5

Clinical significance of pretreatment plasma biomarkers in advanced non-small cell lung cancer patients.

Wang S, Han X, Hu X, Wang X, Zhao L, Tang L, Feng Y, Wu D, Sun Y, Shi Y. Wang S, et al. Among authors: wang x. Clin Chim Acta. 2014 Mar 20;430:63-70. doi: 10.1016/j.cca.2013.12.026. Epub 2013 Dec 27. Clin Chim Acta. 2014. PMID: 24378285

6

Antitumor effects of a novel chromosome region maintenance 1 (CRM1) inhibitor on non-small cell lung cancer cells in vitro and in mouse tumor xenografts.

Wang S, Han X, Wang J, Yao J, Shi Y. Wang S, et al. Among authors: wang j. PLoS One. 2014 Mar 4;9(3):e89848. doi: 10.1371/journal.pone.0089848. eCollection 2014. PLoS One. 2014. PMID: 24595136 Free PMC article.

7

[Methodology comparison and influence factors analysis of epidermal growth factor receptor mutation detection].

Qian X, Wang S, Shen Y, Wu D, Zhang Z, Feng Y, Han X, Shi Y. Qian X, et al. Among authors: wang s. Zhonghua Yi Xue Za Zhi. 2015 Jan 13;95(2):106-11. Zhonghua Yi Xue Za Zhi. 2015. PMID: 25876895 Chinese.

8

Prognostic impact of mutation profiling in patients with stage II and III colon cancer.

Shen Y, Han X, Wang J, Wang S, Yang H, Lu SH, Shi Y. Shen Y, et al. Among authors: wang j, wang s. Sci Rep. 2016 Apr 14;6:24310. doi: 10.1038/srep24310. Sci Rep. 2016. PMID: 27074743 Free PMC article.

9

[Effects of icotinib hydrochloride on the proliferation and apoptosis of human lung cancer cell lines].

Ma L, Han XH, Wang S, Wang JF, Shi YK. Ma L, et al. Among authors: wang jf, wang s. Zhonghua Yi Xue Za Zhi. 2012 Sep 25;92(36):2561-4. Zhonghua Yi Xue Za Zhi. 2012. PMID: 23158799 Chinese.

10

CRM1 as a new therapeutic target for non-Hodgkin lymphoma.

Han X, Wang J, Shen Y, Zhang N, Wang S, Yao J, Shi Y. Han X, et al. Among authors: wang j, wang s. Leuk Res. 2015 Jan;39(1):38-46. doi: 10.1016/j.leukres.2014.10.003. Epub 2014 Nov 4. Leuk Res. 2015. PMID: 25466285 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119,415 results

Search Page

Filters